AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Popularity #828Dividend on the way · $0.05

BRKR · NASDAQ · Medical - Devices

Bruker (BRKR)

Maker of magnetic-resonance, mass-spectrometry, and X-ray instruments for scientific and industrial research.

$60.20

vs last close−1.01 (−1.65%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	743	855	722	801	864	980	801	797	861	977	823	839
Cost of revenue	360	424	369	416	446	486	410	440	481	528	434	423
Gross profit	383	430	353	385	419	493	391	358	379	449	389	416
	258	327	288	337	351	421	359	346	344	337	344	481
Research & development	71	84	82	92	98	104	97	100	98	100	101	94
	178	212	195	221	239	237	225	231	243	247	242	239
General & administrative	178	212	195	221	239	237	225	0	243	247	0	0
Other expenses	9	32	11	23	14	80	37	14	4	−9	1	148
Operating income	125	104	65	48	68	72	32	12	35	112	45	−65
	−5	138	7	−24	−13	−18	−6	−11	−108	−45	−27	25
Interest income	2	2	3	3	2	2	3	3	0	0	5	0
Interest expense	4	4	5	16	12	16	13	16	20	11	12	0
Other non-operating income	1	−142	−12	9	1	0	−6	−4	87	32	15	−25
Income before tax	120	242	72	24	55	55	26	1	−73	67	18	−41
Income tax expense	31	37	20	16	15	41	9	−3	−14	38	3	14
Net income from continuing operations	89	205	52	8	40	14	17	4	−59	29	16	−55
Net income	88	206	51	8	41	14	17	8	−60	26	14	−52
EPS, basic	$0.60	$1.41	$0.35	$0.05	$0.27	$0.09	$0.11	$0.05	−$0.41	$0.10	$0.02	−$0.41
EPS, diluted	$0.60	$1.41	$0.35	$0.05	$0.27	$0.09	$0.11	$0.05	−$0.41	$0.10	$0.02	−$0.41
Weighted average shares, basic	147	146	145	147	152	152	152	152	152	152	152	152
Weighted average shares, diluted	147	146	146	148	152	152	152	152	152	153	153	152
EBITDA	150	283	111	85	118	125	89	72	4	138	89	17
Depreciation & amortization	27	37	35	45	51	53	50	56	56	58	58	58
EBIT	123	245	77	40	67	72	38	16	−52	79	30	−41